Pacira BioSciences, Inc. (NASDAQ:PCRX) has scheduled a conference call for 29th October 2020 at 8:30 AM Eastern Time to announce its 3Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.pacira.com
Earnings Expectation
Pacira BioSciences, Inc. specialty pharma firm, is reporting third quarter earnings results on Thursday 29th October 2020, before market open.
The consensus estimates from Thomson Reuters are income of $ 0.63 per share from $ 115.58 million in revenue. For the full year, analysts predict revenues of $ 428.02 million, while looking forward to income of $ 2.08 per share.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 485.00 million ~ $ 500.00 million
Click Here For More Historical Outlooks Of Pacira BioSciences, Inc.
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for health care practitioners and their patients in the United States. The company develops products based on its proprietary DepoFoam product delivery technology that encapsulates drugs without altering their molecular structure.
